Review ArticlesPlatelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease☆
Under an Elsevier user license
open archive
Abbreviations
CAPTURE
C7E3 AntiPlatelet Therapy in Unstable REfractory angina
EPIC
Evaluation of c7E3 for Prevention of Ischemic Complications
EPILOG
Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade
EPISTENT
Evaluation of Platelet Inhibition in STENTing
HACA
human antichimeric antibody
IMPACT II
Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis-II
MI
myocardial infarction
PARAGON
Platelet IIb/IIIa Antagonism for the Reduction of Acute Coronary Syndrome events in the Global Organization Network
PRISM
Platelet Receptor Inhibition in Ischemic Syndrome Management
PRISM PLUS
Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs
PURSUIT
Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy
RAPPORT
ReoPro And Primary PTCA Organization and Randomized Trial
RESTORE
Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis
Cited by (0)
- ☆
The authors have received research grant support for clinical trials in this field sponsored by Centocor, Inc. (Malvern, Pennsylvania), Eli Lilly and Company (Indianapolis, Indiana), COR Therapeutics (South San Francisco, California), Schering-Plough (Kenilworth, New Jersey), Hoffmann LaRoche (Basel, Switzerland) and Merck (White House Station, New Jersey).
Copyright © 2000 American College of Cardiology. Published by Elsevier Inc. All rights reserved.